We’re excited to be part of DMEA 2025 in Berlin this April and even more thrilled to share that PAICON is a finalist for the Nova Award: Focus Tomorrow’s Technology, celebrating innovation in digital health!
More information on DMEA 2025 ›
What to Expect
Join us to discover how we’re using ethically sourced, genetically diverse cancer data to build AI tools that push the boundaries of cancer diagnostics.
From:
- SatSight DX – our AI that detects MSI in colorectal cancer
- Athena – our foundational model trained on real-world data from around the world
We’re showing how purposeful data drives meaningful change in healthcare.
“Innovation only matters when it’s inclusive. That’s why we’re focused on building diagnostic tools that reflect real-world diversity. Being a Nova Award finalist is a huge honor, and a sign we’re on the right path.”
— Dr. Manasi A‑Ratnaparkhe, CEO & Co‑Founder
Whether you’re in pharma, research, or healthcare; come say hi, explore what we’re working on, and let’s talk about the future of cancer diagnostics.
We’re looking forward to seeing you there!
